Thus, LRP1 may protect against atherosclerosis by attenuating inflammation through a decrease in the cell-surface abundance of the TNF receptor-1, and also by inhibiting the Iκ-B kinase/NF-κB intracellular activation. The gene discussed is LRP1; the disease is atherosclerosis.